- Here’s why slashing insulin prices will actually save Big Pharma money https://arstechnica.com/science/2023/03/heres-why-slashing-insulin-prices-will-actually-save-big-pharma-money/ 5 comments technology
Linking pages
- Big Pharma to raise US list prices of 500 drugs in January: Report | Ars Technica https://arstechnica.com/health/2024/01/big-pharma-to-raise-us-list-prices-of-500-drugs-in-january-report/ 15 comments
- Report: Microsoft cut a key AI ethics team | Ars Technica https://arstechnica.com/tech-policy/2023/03/amid-bing-chat-controversy-microsoft-cut-an-ai-ethics-team-report-says/ 1 comment
Linked pages
- Eli Lilly CEO says insulin tweet flap “probably” signals need to bring down cost | Ars Technica https://arstechnica.com/science/2022/11/eli-lilly-ceo-says-insulin-tweet-flap-probably-signals-need-to-bring-down-cost/ 3097 comments
- Musk’s Twitter chaos tosses outrageous insulin pricing into the spotlight | Ars Technica https://arstechnica.com/science/2022/11/musks-twitter-chaos-tosses-outrageous-insulin-pricing-into-the-spotlight/ 84 comments
- Report: Microsoft cut a key AI ethics team | Ars Technica https://arstechnica.com/tech-policy/2023/03/amid-bing-chat-controversy-microsoft-cut-an-ai-ethics-team-report-says/ 1 comment
- Eli Lilly cuts insulin prices after years of outrage | Ars Technica https://arstechnica.com/science/2023/03/eli-lilly-to-match-medicares-35-insulin-cost-cap-after-furor/ 0 comments
Related searches:
Search whole site: site:arstechnica.com
Search title: Here’s why slashing insulin prices will actually save Big Pharma money | Ars Technica
See how to search.